ArQule (NASDAQ:ARQL) Hits 12-Year High Following Favorable Midstage Study Results

Shares of the small-cap biotech stock ArQule, Inc. (NASDAQ: ARQL) were seeing strength on brisk volume Monday. What Happened Close on the heels of a 30% rally Friday...... Read more on Benzinga

Benzinga

ARQL arqule health-care pharmaceuticals


ContraVir (NASDAQ:CTRV) Moves Higher After NASH Drug Shows 100% Efficacy In Fibrosis Prevention

ContraVir Pharmaceuticals Inc (NASDAQ: CTRV) shares were rallying Monday on positive news related to its non-alcoholic steatohepatitis, or NASH, drug. ContraVir, which came...... Read more on Benzinga

Benzinga

CTRV contravir health-care pharmaceuticals


AKZO NOBEL NV ADR # (AKZOY), (ETCG) - These Were The Most Actively Traded Securities On The OTC Markets In May

Swiss pharmaceutical giant Roche Pharmaceuticals became the first security on OTC Markets to reach $4 billion in dollar trading volume in 2019, according to OTC Markets data...... Read more on Benzinga

Benzinga

VTX:ROG roche-holding health-care pharmaceuticals


What Happened in the Stock Market Today -- The Motley Fool

Acquisitions made headlines, with Pfizer buying Array BioPharma and a private investor picking up Sotheby's.... Read more on The Motley Fool

The Motley Fool

PFE pfizer health-care pharmaceuticals ARRY array-biopharma


Flexion: Finally Looking For An Entry

Flexion Therapeutics recently announced Q1 revenue of only $10.6M but revealed they already had $5.1M in revenue in April. This puts the company on track to hit... Read more on Seeking Alpha

Seeking Alpha

FLXN flexion-therapeutics health-care pharmaceuticals


44 Stocks Moving In Monday’s Mid-Day Session

Gainers Sothebys (NYSE: BID) shares jumped 57.7% to $55.82 after the company announced it will be acquired by BidFair for $57 per share in cash. Array BioPharma Inc. (NASDAQ:...... Read more on Benzinga

Benzinga

ARRY array-biopharma health-care pharmaceuticals


Rockwell Medical slides 23% on new share offering

Rockwell Medical (NASDAQ:RMTI) is 22.9% lower postmarket after launching a share offering. Book-runners are Piper Jaffray and Cantor Fitzgerald. Underwriters will get a 30-day optino to buy up to an... Read more on Seeking Alpha

Seeking Alpha

RMTI rockwell-medical health-care biotechnology


Calithera Biosciences readies secondary offering

Calithera Biosciences (NASDAQ:CALA) announces secondary offering of 10M sharesUnderwriters have an option to purchase up to 1.5M additional sharesPress Release... Read more on Seeking Alpha

Seeking Alpha

CALA calithera-biosciences health-care pharmaceuticals


VBI (NASDAQ:VBIV) Shares Plunge On Mixed Late-Stage Hepatitis B Vaccine Trial Results

VBI Vaccines Inc (NASDAQ: VBIV) shares were in penny stock territory Monday following the release of data from a late-stage study of its hepatitis B virus vaccine candidate....... Read more on Benzinga

Benzinga

VBIV vbi-vaccines health-care biotechnology


Why Iovance Biotherapeutics Stock Jumped Today -- The Motley Fool

Pfizer's acquisition of Array appeared to cause investors to wonder whether a big deal could be in store for Iovance.... Read more on The Motley Fool

The Motley Fool

PFE pfizer health-care pharmaceuticals


Federal Court of Appeal Upholds I-MED Pharma's Patent Win Against TearLab

MONTREAL, June 17, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announced today that the Canadian Federal...... Read more on Benzinga

Benzinga

TEAR tearlab health-care medical/dental-instruments


The Wall Street Journal: Pfizer to buy cancer dug maker Array BioPharma for $10.64 billion

Pfizer Inc. agreed to buy Array BioPharma Inc. for $10.64 billion in cash, as the pharmaceutical company looks to expand its pipeline of cancer therapies.... Read more on MarketWatch

MarketWatch

PFE pfizer health-care pharmaceuticals ARRY array-biopharma


Massive Increase In Short Interest Could Be Setting Bears Up For A Fall In Arrowhead Pharmaceuticals

Arrowhead's most recent share price run has left investors wondering if it has run too far too fast. Short interest has risen significantly with the recent run ... Read more on Seeking Alpha

Seeking Alpha

ARWR arrowhead health-care pharmaceuticals


Scynexis And The Fungal Economy

Scynexis is a development stage biotechnology developing a novel antifungal, Ibrexafungerp, with a high probability of success. Although a competitive landscape... Read more on Seeking Alpha

Seeking Alpha

SCYX scynexis health-care pharmaceuticals


Pfizer makes $10.6 billion cancer bet in cash deal for Array Biopharma

Pfizer Inc on Monday said it would buy Array Biopharma Inc for $10.64 billion in cash, a deal it hopes will help make it a leader in colon cancer and build up its pipeline of oncology drugs.... Read more on Reuters

Reuters

PFE pfizer health-care pharmaceuticals ARRY array-biopharma


Aclaris Announces Positive Results From Alopecia Treatment Trial (NASDAQ:ACRS)

Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced positive six-month results from a Phase 2 clinical trial of ATI-502 for patients with androgenetic alopecia. The trial...... Read more on Benzinga

Benzinga

ACRS aclaris-therapeutics health-care pharmaceuticals


Here's Why ArQule Is Soaring Again Today -- The Motley Fool

A new day, a new batch of promising interim data from an early-stage clinical study.... Read more on The Motley Fool

The Motley Fool

ARQL arqule health-care pharmaceuticals


More